Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue? Over the past ...

They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Gilead's revenue is anchored by Biktarvy, protected by exclusivity through 2036, reducing near-term patent cliff risk vs. peers. Learn more about GILD stock here.

Oracle announced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to empower pharmaceutical, medical device, research, and life sciences organizations to accelerate ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund focuses on long-term, ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Anavex Life Sciences (AVXL) one of those stocks right now? A ...

PHOENIX, Ariz.—A first-of-its-kind space telescope could soon launch into orbit and potentially chart a new path forward for astronomy. “For 20 years, Eric and I have pursued philanthropy to seek new ...